Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.29
Equity-to-Asset	0.38
Debt-to-Equity	0.62
Debt-to-EBITDA	2.51
Interest Coverage	8.52
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Beneish M-Score	-2.88	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

9/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	14.6
	3-Year EBITDA Growth Rate	11.2
	3-Year EPS without NRI Growth Rate	22.4
	3-Year FCF Growth Rate	-9.2
	3-Year Book Growth Rate	7.6
	Future 3-5Y EPS without NRI Growth Rate	7.1
	Future 3-5Y Total Revenue Growth Rate	5.96

Momentum Rank

1/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	35.22
	9-Day RSI	34.84
	14-Day RSI	35.35
	6-1 Month Momentum %	-21.9
	12-1 Month Momentum %	-8.66

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.71
	Dividend Payout Ratio	0.19
	3-Year Dividend Growth Rate	15.9
	Forward Dividend Yield %	1.78
	5-Year Yield-on-Cost %	3.5
	3-Year Average Share Buyback Ratio	1.7
	Shareholder Yield %	2.1

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Net Margin %	3.69
	FCF Margin %	0.48
	ROE %	15.71
	ROA %	5.72
	ROIC %	8.54
	Years of Profitability over Past 10-Year	10

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	13.42
	Forward PE Ratio	10.74
	PE Ratio without NRI	10.93
	Shiller PE Ratio	17.43
	Price-to-Owner-Earnings	384.34
	PEG Ratio	1
	PS Ratio	0.5
	PB Ratio	1.96
	Price-to-Tangible-Book	11.41
	Price-to-Free-Cash-Flow	95.61
	Price-to-Operating-Cash-Flow	39.87
	EV-to-EBIT	11.28
	EV-to-Forward-EBIT	9.63
	EV-to-EBITDA	9.8
	EV-to-Forward-EBITDA	9.09
	EV-to-Revenue	0.61
	EV-to-Forward-Revenue	0.56
	EV-to-FCF	119.7
	Price-to-Projected-FCF	0.65
	Price-to-DCF (Earnings Based)	0.52
	Price-to-DCF (FCF Based)	4.27
	Price-to-Median-PS-Value	0.72
	Price-to-Peter-Lynch-Fair-Value	1.06
	Price-to-Graham-Number	2.35
	Earnings Yield (Greenblatt) %	8.87
	FCF Yield %	0.99
	Forward Rate of Return (Yacktman) %	18.14

Financials (Next Earnings Date:2025-01-24 Est.)

Annual Quarterly TTM

WBO:ELV's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

No Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

No Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

No Enough Data

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

No Enough Data

Elevance Health Inc Operating Data

Annual Quarterly

WBO:ELV's Complete Operating Data

No operating data available for Elevance Health Inc.

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015

Elevance Health Inc Executives

Details

GF Value: €510.66

WBO:ELV

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 4 Medium warning signs with ELV. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	159,500.918
	EPS (TTM) (€)	25.231
	Beta	0.18
	Volatility %	23.47
	14-Day RSI	35.35
	14-Day ATR (€)	6.926783
	20-Day SMA (€)	370.705
	12-1 Month Momentum %	-8.66
	52-Week Range (€)	348 - 513.4
	Shares Outstanding (Mil)	231.92

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Elevance Health Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Elevance Health Inc Stock Events

Financials Calendars

	Event	Date	Price(€)
No Event Data

Elevance Health Inc Frequently Asked Questions

What is Elevance Health Inc(WBO:ELV)'s stock price today?

The current price of WBO:ELV is €353.40. The 52 week high of WBO:ELV is €513.40 and 52 week low is €348.00.

When is next earnings date of Elevance Health Inc(WBO:ELV)?

The next earnings date of Elevance Health Inc(WBO:ELV) is 2025-01-24 Est..

Does Elevance Health Inc(WBO:ELV) pay dividends? If so, how much?

The Dividend Yield % of Elevance Health Inc(WBO:ELV) is 1.71% (As of Today), Highest Dividend Payout Ratio of Elevance Health Inc(WBO:ELV) was 0.28. The lowest was 0.17. And the median was 0.2. The Forward Dividend Yield % of Elevance Health Inc(WBO:ELV) is 1.78%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.